The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Ontario faces more vaccine delays as it struggles to tame third COVID-19 wave

Mon, 19th Apr 2021 22:00

TORONTO, April 19 (Reuters) - Ontario Premier Doug Ford said
on Monday the province expects to face a delay in the supply of
AstraZeneca Plc COVID-19 vaccine, dealing another blow
to its efforts to contain a punishing third wave of the
pandemic.

"In addition to the delayed and cut Moderna shipments, the
Premier was notified today by our officials to be prepared for
delays to two shipments of AstraZeneca expected from the federal
government later this month and next," a statement from Ford's
office said.

Canada's most-populous province said on Sunday it would
lower the minimum age for recipients of the AstraZeneca vaccine
to 40 from 55..

Ontario announced 4,447 new cases on Monday, with a 10.5%
positivity rate and 19 more deaths. The rising caseload - 755
COVID-19 patients in intensive care on Monday - has pushed the
province's hospitals to the brink.

On Friday, the government announced measures including
closing its borders with the provinces of Quebec and Manitoba.
But the following day it reversed its decision to close
playgrounds and amended its granting of extra powers to police
to enforce a stay-at-home order.

Moderna Inc said last week that vaccine shipments
to Canada would be cut to 650,000 doses from 1.2 million.

Before Ontario decided to lower the age group for
AstraZeneca vaccines, doctors and pharmacists had expressed
concern that not enough people were signing up to take the
AstraZeneca shot, citing blood clot fears. Two people in Canada
have developed clots after receiving the shot and are
recovering.

Nadjla Banaei, client care coordinator at the South
Riverdale Community Health Centre in Toronto, has had several
clients express concerns about the AstraZeneca vaccine. They may
have underlying health conditions and worry about what they have
read, she said.

"We've had several people say: 'No, no thanks, we'll wait
for Pfizer and Moderna,'" Banaei said.

The move to lower the age group expands the pool of
potential AstraZeneca recipients but does not necessarily quell
fears around it, she said.

"Why did they drop the age all of a sudden? What are we
supposed to communicate to people? ... Of course, with all these
changes, people are going to be hesitant."

Federal Health Minister Patty Hajdu said over the weekend
that the provinces were free to offer AstraZeneca to anyone over
18.

Alberta and Manitoba have also said they would lower the
age.

(Reporting by Anna Mehler Paperny; Editing by Denny Thomas and
Peter Cooney)

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.